Compare Lupin Ltd with AANJANEYA LIFECARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs DR. DATSONS LABS - Comparison Results

LUPIN     Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN DR. DATSONS LABS LUPIN/
DR. DATSONS LABS
 
P/E (TTM) x 46.7 -10.9 - View Chart
P/BV x 2.4 0.2 1,474.2% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 LUPIN   DR. DATSONS LABS
EQUITY SHARE DATA
    LUPIN
Mar-19
DR. DATSONS LABS
Mar-14
LUPIN/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs986126 785.0%   
Low Rs72031 2,331.4%   
Sales per share (Unadj.) Rs369.5133.0 277.8%  
Earnings per share (Unadj.) Rs13.40.2 8,841.5%  
Cash flow per share (Unadj.) Rs37.46.6 565.8%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs303.7128.8 235.8%  
Shares outstanding (eoy) m452.4931.66 1,429.2%   
Bonus/Rights/Conversions ESOPFCCB-  
Price / Sales ratio x2.30.6 392.5%   
Avg P/E ratio x63.6516.1 12.3%  
P/CF ratio (eoy) x22.811.8 192.7%  
Price / Book Value ratio x2.80.6 462.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m386,0642,477 15,583.5%   
No. of employees `00017.7NA-   
Total wages/salary Rs m31,51356 56,273.0%   
Avg. sales/employee Rs Th9,453.8NM-  
Avg. wages/employee Rs Th1,782.0NM-  
Avg. net profit/employee Rs Th343.0NM-  
INCOME DATA
Net Sales Rs m167,1824,211 3,970.6%  
Other income Rs m3,64079 4,625.4%   
Total revenues Rs m170,8224,289 3,982.6%   
Gross profit Rs m28,822569 5,069.0%  
Depreciation Rs m10,850204 5,308.3%   
Interest Rs m3,078430 715.6%   
Profit before tax Rs m18,53413 145,937.0%   
Minority Interest Rs m-890-   
Prior Period Items Rs m38-2 -2,083.3%   
Extraordinary Inc (Exp) Rs m-3,4000-   
Tax Rs m9,0176 147,818.0%   
Profit after tax Rs m6,0665 126,364.6%  
Gross profit margin %17.213.5 127.7%  
Effective tax rate %48.748.0 101.3%   
Net profit margin %3.60.1 3,182.5%  
BALANCE SHEET DATA
Current assets Rs m138,5366,852 2,021.9%   
Current liabilities Rs m61,2996,711 913.5%   
Net working cap to sales %46.23.3 1,379.6%  
Current ratio x2.31.0 221.4%  
Inventory Days Days84161 52.1%  
Debtors Days Days112318 35.3%  
Net fixed assets Rs m127,5163,673 3,471.7%   
Share capital Rs m905317 285.8%   
"Free" reserves Rs m136,5173,761 3,629.8%   
Net worth Rs m137,4224,078 3,370.3%   
Long term debt Rs m66,4171,671 3,975.2%   
Total assets Rs m279,49412,633 2,212.5%  
Interest coverage x7.01.0 682.0%   
Debt to equity ratio x0.50.4 117.9%  
Sales to assets ratio x0.60.3 179.5%   
Return on assets %3.33.4 95.0%  
Return on equity %4.40.1 3,749.4%  
Return on capital %8.97.7 116.1%  
Exports to sales %022.9 0.0%   
Imports to sales %014.3 0.0%   
Exports (fob) Rs mNA964 0.0%   
Imports (cif) Rs mNA602 0.0%   
Fx inflow Rs m59,414964 6,163.2%   
Fx outflow Rs m22,282607 3,670.2%   
Net fx Rs m37,132357 10,403.9%   
CASH FLOW
From Operations Rs m16,6601,345 1,238.8%  
From Investments Rs m-32,825-2,256 1,455.3%  
From Financial Activity Rs m7,441-1,200 -620.2%  
Net Cashflow Rs m-8,724-2,111 413.3%  

Share Holding

Indian Promoters % 46.6 4.5 1,028.7%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 11.3 0.0 -  
FIIs % 31.9 1.4 2,363.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 94.1 10.7%  
Shareholders   98,259 20,807 472.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   SHASUN PHARMA  DR. REDDYS LAB  GSK PHARMA  UNICHEM LAB  PROCTER & GAMBLE HEALTH  

Compare LUPIN With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Marginally Higher; Energy & Realty Stocks Lead(09:30 am)

Asian share markets are higher today as Britain and the EU made headway on a Brexit deal ahead of a leaders' summit.

Related Views on News

LUPIN Announces Quarterly Results (1QFY20); Net Profit Up 49.3% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, LUPIN has posted a net profit of Rs 3 bn (up 49.3% YoY). Sales on the other hand came in at Rs 44 bn (up 14.6% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (4QFY19); Net Profit Down 1.5% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, LUPIN has posted a net profit of Rs 3 bn (down 1.5% YoY). Sales on the other hand came in at Rs 44 bn (up 77.8% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN LTD Announces Quarterly Results (3QFY19); Net Profit Down 149.7% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, LUPIN LTD has posted a net profit of Rs 2 bn (down 149.7% YoY). Sales on the other hand came in at Rs 45 bn (up 78.0% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD Announces Quarterly Results (2QFY19); Net Profit Down 31.1% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, LUPIN LTD has posted a net profit of Rs 3 bn (down 31.1% YoY). Sales on the other hand came in at Rs 40 bn (up 53.1% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


Oct 16, 2019 10:01 AM

TRACK LUPIN

COMPARE LUPIN WITH

MARKET STATS